✦ LIBER ✦

Analysis of medical costs as a secondary end-point in a clinical trial

✍ Scribed by L.Richard Smith; Daniel B. Mark; Kerry L. Lee; Lynn H. Woodlief; Robert M. Califf

Book ID: 113297267
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 77 KB
Volume: 12
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(91)90125-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Change in Sweat Chloride as a Clinical E

Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical Trials

✍ Durmowicz, Anthony G.; Witzmann, Kimberly A.; Rosebraugh, Curtis J.; Chowdhury, 📂 Article 📅 2013 🏛 American College of Chest Physicians 🌐 English ⚖ 643 KB

Protein C as a surrogate end-point for c

Protein C as a surrogate end-point for clinical trials of sepsis

✍ Kathleen D Liu,Michael A Matthay 📂 Article 📅 2008 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 39 KB

Secondary Analysis of Clinical Trials—A

Secondary Analysis of Clinical Trials—A Cautionary Note

✍ John R. Marler 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Blood in the stomach as a surrogate for

Blood in the stomach as a surrogate for clinical end points in GI bleeding trials

✍ GM Hawkey; WA Stack; AT Cole; RG Long; RFA Logan; CJ Hawkey 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 165 KB

1296 DEVELOPING END POINTS FOR CLINICAL

1296 DEVELOPING END POINTS FOR CLINICAL TRIALS IN PBC: ALKALINE PHOSPHATASE AS A PREDICTOR OF OUTCOME

✍ Meaney, C.; Kumagi, T.; Al-Harthy, N.; Acarsu, U.; Coltescu, C.; Hirschfleld, G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Progression-free survival as an end-poin

Progression-free survival as an end-point in clinical trials of biotherapeutic agents

✍ Lothar Bergmann; Steven Hirschfeld; Charles Morris; Sergio Palmeri; Andrew Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB